当前位置:首页 - 行情中心 - 回盛生物(300871) - 财务分析 - 现金流量表

回盛生物

(300871)

  

流通市值:43.14亿  总市值:43.14亿
流通股本:2.02亿   总股本:2.02亿

现金流量表

报告期2025-06-302025-03-312024-12-312024-09-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
  销售商品、提供劳务收到的现金639,310,182.87326,279,066.99993,405,077.95700,635,232.4
  收到的税费返还8,262,739.3-2,870,091.872,415,943.14
  收到其他与经营活动有关的现金17,770,597.135,976,185.1530,767,615.9624,628,102.93
  经营活动现金流入小计665,343,519.3332,255,252.141,027,042,785.78727,679,278.47
  购买商品、接受劳务支付的现金393,921,808.8202,385,667.68716,596,742.24537,880,787.04
  支付给职工以及为职工支付的现金75,869,225.342,278,375.73136,269,452.92102,566,365.58
  支付的各项税费30,343,922.0510,861,356.9243,135,292.8623,901,686.77
  支付其他与经营活动有关的现金41,355,837.5618,769,587.6587,509,450.9556,219,795.45
  经营活动现金流出小计541,490,793.71274,294,987.98983,510,938.97720,568,634.84
  经营活动产生的现金流量净额123,852,725.5957,960,264.1643,531,846.817,110,643.63
二、投资活动产生的现金流量:
  收回投资收到的现金273,934,405.6495,116,974.52660,289,533.07525,530,535.54
  取得投资收益收到的现金3,637,846.49667,432.58,185,734.797,473,427.96
  处置固定资产、无形资产和其他长期资产收回的现金净额380,000380,000422,636.0892,440.77
  投资活动现金流入小计277,952,252.1396,164,407.02668,897,903.94533,096,404.27
  购建固定资产、无形资产和其他长期资产支付的现金51,722,454.4338,179,940.01194,426,199.53168,406,143.06
  投资支付的现金345,450,000185,450,000576,286,492.54491,434,530.68
  投资活动现金流出小计397,172,454.43223,629,940.01770,712,692.07659,840,673.74
  投资活动产生的现金流量净额-119,220,202.3-127,465,532.99-101,814,788.13-126,744,269.47
三、筹资活动产生的现金流量:
  吸收投资收到的现金--19,495,458685,001
  其中:子公司吸收少数股东投资收到的现金--3,140,958685,001
  取得借款收到的现金180,000,000120,000,000480,000,000360,000,000
  收到其他与筹资活动有关的现金23,658,1784,116,22056,592,01462,740,242
  筹资活动现金流入小计203,658,178124,116,220556,087,472423,425,243
  偿还债务支付的现金214,074,853.9285,000,000479,555,978.39339,620,272.9
  分配股利、利润或偿付利息支付的现金25,965,207.352,487,468.8659,155,946.5250,820,249.65
  支付其他与筹资活动有关的现金354,500272,0003,399,179.433,335,138.45
  筹资活动现金流出小计240,394,561.2787,759,468.86542,111,104.34393,775,661
  筹资活动产生的现金流量净额-36,736,383.2736,356,751.1413,976,367.6629,649,582
四、汇率变动对现金及现金等价物的影响108,497.32404,235.28-613,772.49-178,476.97
五、现金及现金等价物净增加额-31,995,362.66-32,744,282.41-44,920,346.15-90,162,520.81
  加:期初现金及现金等价物余额184,591,943.24184,591,943.24229,512,289.39229,512,289.39
  期末现金及现金等价物余额152,596,580.58151,847,660.83184,591,943.24139,349,768.58
补充资料:
  净利润117,545,832.95--19,773,164.88-
  资产减值准备2,142,279.23-660,419.44-
  固定资产和投资性房地产折旧57,390,335.2-110,255,352.79-
  其中:固定资产折旧、油气资产折耗、生产性生物资产折旧57,390,335.2-110,255,352.79-
  无形资产摊销1,688,957.46-3,030,435.91-
  长期待摊费用摊销291,280.01-759,869.74-
  固定资产报废损失21,157.69-208,272.14-
  公允价值变动损失-7,488,537.35-23,638,504.81-
  财务费用11,383,103.99-42,814,265.18-
  投资损失-3,616,674.49--8,185,502.6-
  递延所得税2,447,778.39--19,559,762.92-
  其中:递延所得税资产减少6,099,537.92--5,515,078.67-
    递延所得税负债增加-3,651,759.53--14,044,684.25-
  存货的减少1,018,015.3--20,834,632.15-
  经营性应收项目的减少14,177,420.75--210,124,792.87-
  经营性应付项目的增加-70,438,111.79-136,381,609.48-
  其他-2,710,111.75-4,260,972.74-
  现金的期末余额152,596,580.58-184,591,943.24-
  减:现金的期初余额184,591,943.24-229,512,289.39-
  现金及现金等价物的净增加额-31,995,362.66--44,920,346.15-
公告日期2025-08-062025-04-292025-04-292024-10-30
审计意见(境内)标准无保留意见
TOP↑